The latest news from PTC

PTC UK was the first office to open in Europe and hire the first employees to serve our patients in the region. Today, 23 employees are based in the UK, leading regional and global functions. In the last 10 years, the PTC UK team have worked in partnership with the scientific and rare disease community…

Since 2014, the PTC office in Ireland has been the company’s international headquarters and a regional hub. With nine departments and more than 50 employees*, the cross-functional teams facilitate supply of PTC’s medicines across 50+ geographies, manage global quality operations and global pharmacovigilance activities as well as commercial sales and finances for Europe, Middle East…

It has been 10 years since PTC entered the European market with a mission to improve the lives of people living with rare diseases.  In the past decade, we have pioneered transformative progress and created possibilities for the rare disease community across Europe. PTC was founded with the mission to leverage its novel drug discovery…

PTC’s geographical footprint continues to expand as we fulfill our mission to provide access to best-in-class treatments for more patients around the world. Our recent expansion into Kazakhstan is a further achievement in this mission. In the first quarter of 2023, PTC officially opened its affiliate office in Almaty and hired the first employees.  Today,…

On Monday, June 26, in acknowledgement of PTC’s 10th anniversary as a public company, PTC had the unique opportunity to open the Nasdaq stock exchange in New York City. The special opening bell ceremony event was held from 8:30 – 10:00 a.m. at the Nasdaq MarketSite in Times Square. Dr. Matthew Klein, CEO, was joined…

Debbie Hart always picks up the phone when PTC calls. As the President and CEO of BioNJ, the life sciences trade association for New Jersey, she has been observing and living through every moment with PTC since the company was founded in 1998, by Stuart Peltz, Founding CEO of PTC, and the partnership with BioNJ.…

2023 is a meaningful, unique and thrilling year for PTC. It’s the company’s 25th anniversary, and it is poised to be a year of momentum as we anticipate significant trial readouts in multiple disease areas. We’re also working toward our ambitious goal to produce a therapy every two to three years based on our robust…

PTC was thrilled to be shortlisted as a finalist in the Pharma Industry Awards in two categories, Biotech Company of the Year and Supply Chain Achievement Award, alongside remarkable companies and organizations in Ireland’s pharma industry. The Pharma Industry Awards recognize and celebrate the most original and innovative individuals and companies that demonstrate excellence in…

On the 1st of September 2022, PTC Therapeutics officially opened it’s the newly established office, located in Warsaw, Poland. The new office marks an important milestone for our company and the patients we serve. PTC’s roots in Poland have already existed for several years, during which we have been invested in supporting the rare disease…

Alethia Young’s journey to become a PTC Board Member began with a reverence for doctors. When she was young, her grandfather had glioblastoma, which resulted in long stints in the hospital. It was during this time that she began to idolize the doctors and nurses caring for her grandfather, and decided she wanted to become…